Generic drug maker Sandoz has secured a retroactive licence to manufacture a cheaper version of top-selling antidepressant Lexapro, the drug at the heart of a long-running patent infringement battle with pharmaceutical giant Lundbeck.
ANZ settles class actions by 7-Eleven franchisees
Racing Victoria sues fantasy sports betting co. PlayUp over ‘Best Bets’ trade marks
ACCC, FBI to step up cartel busting cooperation
Rugby League stand-down rule ‘draconian’, court hears at Jack de Belin trial
Mills Oakley’s fee fight with ex-client back on after court sets aside judgment for law firm
Common fund bid in toxic foam class action dismissed after applicant bristles at more scrutiny
A judge has tossed an application for a common fund order in a class action over the use of toxic foam on a RAAF base near Katherine, NT after a barrister for the lead applicants said the bid would be withdrawn if the judge appointed an independent “contradictor” to scrutinise the proposed funding structure.